Strategic leadership With a recent leadership transition including a new CEO in 2026 and ongoing executive changes, there are opportunities to engage Samsara Vision through partnership discussions, advisory roles, and continuity-focused outreach to ensure alignment with strategic priorities in implantable ophthalmic devices.

Market expansion Samsara Vision has active international engagement, including European representation and MDR consulting, plus earlier clinical activity in Italy. Sales opportunities exist in Europe and other regulated markets via distribution partnerships, clinical collaboration programs, and reimbursement strategy support.

Clinical adoption The core product IMT targets end-stage AMD with FDA-approved indications. There is potential to expand installed bases through surgeonенд relationships, patient referral networks, KOL engagement, and joint case studies to demonstrate real-world benefits and drive adoption.

Strategic partnerships Existing partnerships with healthcare providers and support programs can be extended into strategic services, such as training, postoperative care, and data collection, enabling enhanced customer value and higher referral activity from ophthalmic centers.

Financial readiness Current revenue trajectory and mid-market size suggest targeting accounts with reimbursement potential and favorable payer pathways. Develop value-based selling materials, payer engagement kits, and regional pilots to accelerate revenue growth and patient access.